These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16826348)

  • 1. Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
    Saito T; Asai O; Dobashi N; Yano S; Osawa H; Takei Y; Takahara S; Ogasawara Y; Yamaguchi Y; Minami J; Usui N
    J Infect Chemother; 2006 Jun; 12(3):148-51. PubMed ID: 16826348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
    Nevill TJ; Benstead TJ; McCormick CW; Hayne OA
    Am J Hematol; 1989 Dec; 32(4):314-5. PubMed ID: 2554727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: neuropathy due to cytosine arabinoside.
    Russell JA; Powles RL
    Br Med J; 1974 Dec; 4(5945):652-3. PubMed ID: 4374291
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukaemia.
    Paul M; Joshua D; Rahme N; Pollard J; Ell J; Gibson J; Bonnet D
    Br J Haematol; 1991 Nov; 79(3):521-3. PubMed ID: 1661126
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Openshaw H; Slatkin NE; Stein AS; Hinton DR; Forman SJ
    Cancer; 1996 Nov; 78(9):1899-905. PubMed ID: 8909309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system toxicity with high-dose cytosine arabinoside.
    Herzig RH; Lazarus HM; Herzig GP; Coccia PF; Wolff SN
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):233-6. PubMed ID: 3892703
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
    Powell BL; Capizzi RL; Lyerly ES; Cooper MR
    J Clin Oncol; 1986 Jan; 4(1):95-7. PubMed ID: 3001234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity associated with systemic high-dose cytosine arabinoside.
    Nand S; Messmore HL; Patel R; Fisher SG; Fisher RI
    J Clin Oncol; 1986 Apr; 4(4):571-5. PubMed ID: 3457102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
    Caballero MD; González M; Cañizo MC; Orfao A; Nieto MJ; San Miguel JF
    Leukemia; 1992 Aug; 6(8):856-8. PubMed ID: 1640739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation.
    Johnson NT; Crawford SW; Sargur M
    Bone Marrow Transplant; 1987 Aug; 2(2):203-7. PubMed ID: 3332167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
    Altundag O; Altundag K; Celik I; Turker A; Kars A
    Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
    Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
    Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial hypertension secondary to high dose cytosine arabinoside - A case study.
    Nurgat ZA; Alzahrani H; Lawrence M; Mannan A; Ashour M; Rasheed W; Aljurf M
    J Infect Chemother; 2017 May; 23(5):319-322. PubMed ID: 28011351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of idarubicin/cytosine arabinoside versus daunorubicin/cytosine arabinoside in the treatment of adults with acute myeloid leukemia.
    Pashko S; Jacobs J; Santorsa J
    Clin Ther; 1991; 13(3):353-60. PubMed ID: 1954636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.